Rothschild Soto
ScholarGPS® ID: 39731957102194
Affiliation History
Field
Medicine
Discipline
Hematology
Top Specialties
Cisplatin
Metrics Summary
Publication Count
5
Predicted Citations
270
Predicted h-index
5
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Phase Ib/II Trial of Gemcitabine, Cisplatin, and Lenalidomide as First-Line Therapy in Patients With Metastatic Urothelial Carcinoma (journal article) The Oncologist, volume 19, issue 9, pages 915-916 (2014). |
Phase Ib study of dovitinib in combination with gemcitabine plus cisplatin or gemcitabine plus carboplatin in patients with advanced solid tumors (journal article) Cancer Chemotherapy and Pharmacology, volume 74, issue 3, pages 465-471 (2014). |
Characterization of a novel CRAC inhibitor that potently blocks human T cell activation and effector functions (journal article) Molecular Immunology, volume 54, issue 3-4, pages 355-367 (2013). |
British Journal of Pharmacology, volume 160, issue 6, pages 1387-1398 (2010). |
Electrophysiological determination of antagonist mechanism of action at a P2X2‐3 chimeric receptor (journal article) The FASEB Journal, volume 22, issue S2, pages 626-626 (2008). |